ProKidney Corp. (PROK) stock
PROKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.10+0.06 (+5.77%)
Close on Nov 17, 2026Market cap $332.56MP/E –Yield –
ProKidney revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
ProKidney's revenue for the twelve months ending Jun 30, 2026 was $818.00K, up 55.2% year over year. For fiscal 2025 it was $893.00K, up 1075.0% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $893.00K | +1075.0% |
| FY2024 | Dec 31, 2024 | $76.00K | – |
| FY2023 | Dec 31, 2023 | $0 | – |
| FY2022 | Dec 31, 2022 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $150.00K | -32.1% |
| Q1 FY2026 | Mar 31, 2026 | $226.00K | -1.7% |
| Q4 FY2025 | Dec 31, 2025 | $225.00K | +196.1% |
| Q3 FY2025 | Sep 30, 2025 | $217.00K | – |
| Q2 FY2025 | Jun 30, 2025 | $221.00K | – |
| Q1 FY2025 | Mar 31, 2025 | $230.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $76.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $0 | – |
| Q2 FY2024 | Jun 30, 2024 | $0 | – |
| Q1 FY2024 | Mar 31, 2024 | $0 | – |
See a number that looks wrong?